Literature DB >> 11384532

VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait.

L Poirel1, V O Rotimi, E M Mokaddas, A Karim, P Nordmann.   

Abstract

Two clinical Pseudomonas aeruginosa isolates from patients in intensive care units in Kuwait were resistant to expanded-spectrum cephalosporins and showed a synergistic effect between ceftazidime and clavulanic acid. This is the first report of extended-spectrum enzymes from nosocomial isolates from the Middle East.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11384532      PMCID： PMC2631808          DOI： 10.3201/eid0703.010322

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  20 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 4.  Class 1 integrons, gene cassettes, mobility, and epidemiology.

Authors:  A C Fluit; F J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-11       Impact factor: 3.267

5.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

6.  Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa.

Authors:  T Naas; L Poirel; A Karim; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  1999-07-15       Impact factor: 2.742

7.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.

Authors:  W Y Jamal; K El-Din; V O Rotimi; T D Chugh
Journal:  J Hosp Infect       Date:  1999-09       Impact factor: 3.926

9.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases.

Authors:  P Nordmann; T Naas
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191
View more
  23 in total

Review 1.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.

Authors:  Laurent Poirel; Marc Van De Loo; Hedi Mammeri; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria.

Authors:  Daniel Aubert; Thierry Naas; Marie-Frédérique Lartigue; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure.

Authors:  Zhiyong Zong; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

5.  ISCR2, another vehicle for bla(VEB) gene acquisition.

Authors:  Laurent Poirel; Pauline D Mugnier; Mark A Toleman; Timothy R Walsh; Melina J Rapoport; Alejandro Petroni; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

6.  Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene.

Authors:  Thierry Naas; Daniel Aubert; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

7.  Identification of Novel VEB β-Lactamase Enzymes and Their Impact on Avibactam Inhibition.

Authors:  Sushmita D Lahiri; Richard A Alm
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Nosocomial dissemination of extended-spectrum β-lactamase VEB-1a-producing Providencia stuartii isolates in a Tunisian hospital.

Authors:  H Lahlaoui; L Poirel; M B Moussa; M Ferjani; B Omrane; P Nordmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-27       Impact factor: 3.267

9.  Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.

Authors:  Craig J McPherson; Lisa M Aschenbrenner; Brian M Lacey; Kelly C Fahnoe; Margaret M Lemmon; Steven M Finegan; Baswanth Tadakamalla; John P O'Donnell; John P Mueller; Andrew P Tomaras
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

10.  Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India.

Authors:  Daniel Aubert; Delphine Girlich; Thierry Naas; Shanta Nagarajan; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.